Prognostic role of epidermal growth factor receptor in nasopharyngeal carcinoma: A meta‐analysis

Authors:

Abstract
Background: Various studies have assessed the prognostic value of epidermal growth factor receptor (EGFR) overexpression in nasopharyngeal carcinoma (NPC), but their results remain controversial.Methods: Studies published up to January 2013 were collected. A total of 16 studies involving 1179 patients were reviewed. A meta‐analysis was performed to clarify the prognostic role of EGFR in patients with NPC. The combined hazard ratio (HR) and 95% confidence interval (CI) were estimated using fixed‐effects or random‐effects models.Results: EGFR overexpression had significantly poor effect on overall survival (OS; HR, 1.86; 95% CI, 1.25–2.77), disease‐free survival (DFS; HR, 2.25; 95% CI, 1.66–3.04) and locoregional control (HR, 2.93; 95% CI, 1.71–5.02). However, the association between EGFR overexpression and distant metastasis–free survival was not statistically significant (HR, 1.39; 95% CI, 0.72–2.67).Conclusion: EGFR overexpression can be a prognostic factor for patients with NPC. © 2013 Wiley Periodicals, Inc. Head Neck, 36: 1508–1516, 2014

This publication has 44 references indexed in Scilit: